Clinical Trial Update: Randomized Study of Intravenous Immunoglobulin in Patients With Mild or Moderate Myasthenia Gravis [NA]

View source ↗

Summary

This clinical trial update notes that the randomized study of intravenous immunoglobulin in patients with mild or moderate myasthenia gravis has been terminated…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myasthenia Gravis

Drugs mentioned

• Intravenous immunoglobulin (IVIG) (intravenous immunoglobulin)

Snippet

Sponsor: University of Texas | Conditions: Myasthenia Gravis | NA | Status: TERMINATED